LFG
ZVRA icon

Larson Financial Group’s Zevra Therapeutics ZVRA Stock Holding History

Larson Financial Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.41K Hold
473
– – ﹤0.01% 2663
2025
Q4 		$4.24K Buy
473
+65
+16% +$615 ﹤0.01% 2523
2025
Q3 		$3.88K Buy
408
+15
+4% +$150 ﹤0.01% 2443
2025
Q2 		$3.46K Buy
393
+283
+257% +$2.3K ﹤0.01% 2224
2025
Q1 		$824 Hold
110
– – ﹤0.01% 2437
2024
Q4 		$917 Sell
110
-1
-0.9% -$9 ﹤0.01% 2061
2024
Q3 		$770 Hold
111
– – ﹤0.01% 2040
2024
Q2 		$544 Hold
111
– – ﹤0.01% 1821
2024
Q1 		$644 Hold
111
– – ﹤0.01% 1521
2023
Q4 		$727 Buy
+111
New +$519 ﹤0.01% 1528

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return